PubRank
Search
About
Claudine T Jurkovitz
Author PubWeight™ 20.50
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction.
JAMA
2002
2.58
2
Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).
Am J Kidney Dis
2010
2.18
3
Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP).
Arch Intern Med
2007
2.14
4
Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study.
Kidney Int
2003
2.04
5
Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.
Am Heart J
2008
1.46
6
CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
Am J Kidney Dis
2008
1.37
7
Racial and ethnic differences in mortality among individuals with chronic kidney disease: results from the Kidney Early Evaluation Program (KEEP).
Clin J Am Soc Nephrol
2011
1.13
8
Racial and ethnic differences in albuminuria in individuals with estimated GFR greater than 60 mL/min/1.73 m(2): results from the Kidney Early Evaluation Program (KEEP).
Am J Kidney Dis
2010
1.09
9
Advances in CKD detection and determination of prognosis: executive summary of the National Kidney Foundation-Kidney Early Evaluation Program (KEEP) 2012 annual data report.
Am J Kidney Dis
2013
1.02
10
Association of physician care with mortality in Kidney Early Evaluation Program (KEEP) participants.
Am J Kidney Dis
2012
0.92
11
Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial).
Am J Cardiol
2013
0.92
12
Risk factors for chronic kidney disease among American Indians and Alaska Natives--findings from the Kidney Early Evaluation Program.
Am J Nephrol
2008
0.88
13
Comparison of recovery after mitral valve repair and replacement.
J Thorac Cardiovasc Surg
2007
0.82
14
Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease.
Am J Cardiol
2009
0.81
15
Obesity is associated with family history of ESRD in incident dialysis patients.
Am J Kidney Dis
2006
0.80
16
Reduced 6-month resource use and costs associated with cilostazol in patients after successful coronary stent implantation: results from the Cilostazol for RESTenosis (CREST) trial.
Am Heart J
2006
0.79